A LEADING paper that discusses how antimalarial drug hydroxychloroquine can increase the risk of death in coronavirus patients has been withdrawn due to data concerns.
Friday, 5 June 2020
Controversial antimalarial drug study withdrawn as authors deny its authenticity
A LEADING paper that discusses how antimalarial drug hydroxychloroquine can increase the risk of death in coronavirus patients has been withdrawn due to data concerns.
0 comments:
Post a Comment